ES2479541T1 - Micropartículas que comprenden células madre de tejido adiposo - Google Patents

Micropartículas que comprenden células madre de tejido adiposo Download PDF

Info

Publication number
ES2479541T1
ES2479541T1 ES09796382.1T ES09796382T ES2479541T1 ES 2479541 T1 ES2479541 T1 ES 2479541T1 ES 09796382 T ES09796382 T ES 09796382T ES 2479541 T1 ES2479541 T1 ES 2479541T1
Authority
ES
Spain
Prior art keywords
stem cells
adipose tissue
microparticles
tissue stem
approximately
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
ES09796382.1T
Other languages
English (en)
Inventor
Carlo Zanotti Acero
Jesús MEDINA ALONSO
Jesús OROFINO VEGA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tigenix SA
Original Assignee
Cellerix SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellerix SA filed Critical Cellerix SA
Publication of ES2479541T1 publication Critical patent/ES2479541T1/es
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/72—Chitin, chitosan
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/74—Alginate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Una estructura tridimensional que tiene una dimensión máxima entre aproximadamente 1 μm y aproximadamente 100 μm y que comprende células madre derivadas de tejido adiposo y uno o más agentes adhesivos

Claims (1)

  1. imagen1
ES09796382.1T 2008-12-19 2009-12-21 Micropartículas que comprenden células madre de tejido adiposo Pending ES2479541T1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08382081 2008-12-19
EP08382081 2008-12-19
PCT/EP2009/067660 WO2010070141A2 (en) 2008-12-19 2009-12-21 Compositions comprising adipose stem cells

Publications (1)

Publication Number Publication Date
ES2479541T1 true ES2479541T1 (es) 2014-07-24

Family

ID=40677448

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09796382.1T Pending ES2479541T1 (es) 2008-12-19 2009-12-21 Micropartículas que comprenden células madre de tejido adiposo

Country Status (5)

Country Link
US (1) US20120308529A1 (es)
EP (1) EP2376069B1 (es)
JP (1) JP2012512846A (es)
ES (1) ES2479541T1 (es)
WO (1) WO2010070141A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9192695B2 (en) 2008-11-20 2015-11-24 Allosource Allografts combined with tissue derived stem cells for bone healing
US20140286911A1 (en) 2013-03-15 2014-09-25 Allosource Cell repopulated collagen matrix for soft tissue repair and regeneration
ES2600321T3 (es) 2011-08-04 2017-02-08 Ethianum Betriebsgesellschaft Mbh & Co. Kg Medios para la regeneración del hígado
EP2745840B1 (en) 2011-08-16 2017-07-12 Samsung Life Public Welfare Foundation Composition including stem cell-derived microvesicles for use in promoting neurogenesis
US20190060365A1 (en) * 2017-08-25 2019-02-28 Meridigen Biotech Co., Ltd. Pharmaceutical composition for treating chronic obstructive pulmonary disease and method thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687505B2 (en) * 2002-01-14 2010-03-30 Board Of Trustees Of The University Of Illinois Use of modified pyrimidine compounds to promote stem cell migration and proliferation
AU2004285480B2 (en) * 2003-10-22 2010-12-16 Encelle, Inc. Bioactive hydrogel compositions for regenerating connective tissue
JP2006051157A (ja) * 2004-08-11 2006-02-23 Olympus Corp 軟骨化カプセル
US20070134209A1 (en) * 2005-12-12 2007-06-14 Metafluidics, Inc. Cellular encapsulation for self-assembly of engineered tissue
EP2669368B1 (en) * 2006-05-17 2016-08-03 Cognate Therapeutics, Inc. Isolation and purification of hematopoietic stem cells from post-liposuction lipoaspirates
EP2032149A4 (en) * 2006-06-13 2010-09-01 Fmc Biopolymer As METHOD AND SYSTEMS FOR THE USE OF BIOPOLYMER-BASED BEADS AND HYDROGELS
JP5248492B2 (ja) * 2006-07-14 2013-07-31 エフエムシー バイオポリマー エイエス 低分子量アルギネートを含むヒドロゲルおよびそれから製造されたバイオ構造物
CN104906126B (zh) * 2007-02-21 2019-05-28 持田制药株式会社 用于治疗软骨疾病的组合物
US8114668B2 (en) * 2007-05-14 2012-02-14 Cardiac Pacemakers, Inc. Composition for cold storage of stem cells
CN101285053A (zh) * 2008-05-28 2008-10-15 大连理工大学 一种动态悬浮条件下共同培养脐血造血干细胞与间充质干细胞的方法

Also Published As

Publication number Publication date
EP2376069B1 (en) 2019-03-20
US20120308529A1 (en) 2012-12-06
JP2012512846A (ja) 2012-06-07
EP2376069A2 (en) 2011-10-19
WO2010070141A2 (en) 2010-06-24
WO2010070141A3 (en) 2010-09-10

Similar Documents

Publication Publication Date Title
CO6210786A2 (es) Implemento de cuidado oral que alberga un agente de cuidado oral
BRPI0920808A2 (pt) hipersustentador disposto na área de sustenção de uma aeronave
ITVA20110027A1 (it) Composizioni per la cura della persona
BR112015000522A2 (pt) inserção absorvente com entalhe de posicionamento
ES2479541T1 (es) Micropartículas que comprenden células madre de tejido adiposo
ITMI20111697A1 (it) Macchina per l'applicazione di make-up facciale e procedimento di applicazione di make-up utilizzante la stessa
FR2929244B1 (fr) Espace de travail et de rangement a l'arriere d'une cabine d'aeronef
GT201200276A (es) Combinaciones de compuestos activos
AU325183S (en) Camera enclosure
EP2265963A4 (en) CONNECTION DEVICES RELATED TO POWER MANAGEMENT AND RELATED METHODS
BR112014014057A2 (pt) composições de cuidado oral branqueadoras
AR118760A2 (es) Coaglomerados de manitol y de almidón granular comprimibles y de libre fluidez
ATE482201T1 (de) Vr1-benzimidazolmodulatoren
BRPI0816843A2 (pt) Arranjo de conexão entre um implante dentário e um suporte
AU324999S (en) Camera enclosure
GT200600414A (es) Sal de glucuranato de compuesto de piperazine
ATE515242T1 (de) Resorbierbares implantat zum einbringen in einen alvoeolarraum
BR112014018965A8 (pt) Detentor biológico implantável
DOP2006000290A (es) Moduladores de estrógenos
AU346749S (en) Drape for an organ or tissue transporter
ITUD20070032A1 (it) Isolatore sismico e procedimento per realizzare tale isolatore sismico
ITMI20112169A1 (it) Procedimento e dispositivo per la rappresentazione di una sezione di unambiente
AR081308A1 (es) Hilo dental elastomerico
EP2370109A4 (en) MODULATION ASSOCIATED WITH INDEGRINE ALPHA 6 INOGRINE ISOFORM SPLIT PROLIFERATION
BR112012029487A2 (pt) composições de cuidado oral e métodos